跳至主要内容
临床试验/CTRI/2025/04/084399
CTRI/2025/04/084399尚未招募不适用

Comparative Study Of Aamra (Mangifera indica)i.e. Aamra Pallav, Aamra Pushpa And Aamra Twak In Prameha With Special Reference To Diabetes Mellitus

K.G.Mittal Ayurved College And Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年4月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
efficacy of Aamra pallav(mangnifera indica linn)in reducing prameha /Diabetes Mellitus - parameter being blood sugar leval fasting and post prandial blood sugar level And hba1c

研究概览

简要总结

90 Patients presenting with symptoms of prameha will be selected by Randomized method (Alternate individual will be selected ). Selected individuals will be divided into three equal groups. Group will be divided into Group A , Group B  and Group C with 30 individuals in each groups . Symptoms of prameha will be assessed by using blood sugar level ,Hba1c and urine glucose .

Group A will be given Aamra patra churna 5 gram BD with koshna jala And Group B will be given Aamra twak churna 5gram BD with koshna jala  And Group C will be given Aamra pushpa churna 5gram BD with koshna jala Pragbhakta for 3 month for 3 drugs .After intervention , the measurement parameter and symptoms of prameha of Group A, Group B And Group C individual will be reassessed by using the subjective and objective criteria

Generated data will be subjected to appropriate statistical test and conculsion will be drawn using statistical and observations found in study .

the pharmacognostical study , physical analysis , chemical analysis of three drugs will be studied during the trial

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Blood sugar level Fasting 125mg/dl to 250mg/dl post Prandial 150mg/dl&350mg/dl 2.HbA1C 6.5 %&10%.

排除标准

  • 1.Patient below 18YRS to Above 70 Yrs 2.Patient with type 1 diabetes Mellitus 3.Patient With Malignant Condition And Accelerated hypertension and Systematic Disease 4.Patient With Known Complication Of DM 5.Pregnant women and Lactating mother.

结局指标

主要结局

efficacy of Aamra pallav(mangnifera indica linn)in reducing prameha /Diabetes Mellitus - parameter being blood sugar leval fasting and post prandial blood sugar level And hba1c

时间窗: FROM START AND AFTER 3 MONTH

2.Efficacy of Aamra twak (mangnifera indica linn)in reducing prameha/ Diabetes Mellitus- parameter being blood sugar level (fasting and post prandial)and hba1c

时间窗: FROM START AND AFTER 3 MONTH

3.Efficacy Aamra pushpa (Mangnifera indica linn.)in reducing prameha/Diabetes mellitus parameter being blood sugar level (fasting and post pradinal )and hba1c

时间窗: FROM START AND AFTER 3 MONTH

4.Comparison between Aamra pallav , Aamra twak and Aamra pushpa churna in prameha

时间窗: FROM START AND AFTER 3 MONTH

次要结局

  • Authentication and standardization-analytical study(1.Pharmacognosy -macroscopic and microscopic studies)

研究者

发起方
K.G.Mittal Ayurved College And Hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Swati Rammohan Tiwari

Maharashtra University Of Health Science , Nashik

研究点 (1)

Loading locations...

相似试验